GD-iMphs had a decreased GBA1 activity and stored glucosylceramide and glucosylsphingosine; GD-neurons derived from patients with Parkinsonism had a reduced dopamine storage, a reduced dopamine transporter reuptake and elevated α-synuclein levels. This evidence concerns the gene SNCA and Parkinson disease.